Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  05:13 2022-12-02 am EST
0.5900 EUR   -6.20%
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Surge Higher in Monday Trading

10/03/2022 | 11:09am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABB LTD 0.51% 29.69 Delayed Quote.-12.21%
AMARIN CORPORATION PLC 3.48% 1.19 Delayed Quote.-64.69%
ASCENDIS PHARMA A/S -1.06% 121.75 Delayed Quote.-9.50%
BP PLC -2.42% 477.75 Delayed Quote.48.09%
BRENT OIL -0.14% 87.12 Delayed Quote.9.01%
CARNIVAL CORPORATION 0.40% 9.97 Delayed Quote.-50.45%
DBV TECHNOLOGIES -0.73% 2.736 Real-time Quote.-9.91%
ERICSSON 1.50% 68.22 Delayed Quote.-32.67%
ERYTECH PHARMA S.A. -6.20% 0.59 Real-time Quote.-70.33%
MEREO BIOPHARMA GROUP PLC 0.33% 0.7907 Delayed Quote.-50.58%
NATUZZI S.P.A. 4.32% 6.155 Delayed Quote.-61.36%
SEQUANS COMMUNICATIONS S.A. 0.00% 3.71 Delayed Quote.-21.73%
TOTALENERGIES SE -1.42% 58.41 Real-time Quote.32.80%
TRINITY BIOTECH PLC -3.01% 1.29 Delayed Quote.-9.79%
VODAFONE GROUP PLC 0.01% 91.5253 Delayed Quote.-18.48%
WTI 0.01% 81.363 Delayed Quote.4.48%
All news about ERYTECH PHARMA S.A.
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/22Transcript : ERYTECH Pharma S.A., Q3 2022 Earnings Call, Nov 22, 2022
CI
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
GL
11/21ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
AQ
11/21ERYTECH Pharma S.A. Reports Earnings Results for the Nine Months Ended September 30, 20..
CI
11/18Pharmaceutical Stocks Help European Equities Nudge Higher to End Quiet Week
MT
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/08European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
MT
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,49 M 9,49 M
Net income 2022 -52,8 M -54,4 M -54,4 M
Net Debt 2022 1,50 M 1,55 M 1,55 M
P/E ratio 2022 -0,28x
Yield 2022 -
Capitalization 19,5 M 20,1 M 20,1 M
EV / Sales 2022 2,28x
EV / Sales 2023 1,45x
Nbr of Employees 149
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 0,63 €
Average target price 3,60 €
Spread / Average Target 473%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-70.33%20
VERTEX PHARMACEUTICALS46.07%81 217
REGENERON PHARMACEUTICALS, INC.19.03%80 283
BIONTECH SE-34.26%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S25.29%29 594